Conditional survival in Canada: adjusting patient prognosis over time.
作者信息
Bryant H, Lockwood G, Rahal R, Ellison L
机构信息
Canadian Partnership Against Cancer, Toronto, ON.
出版信息
Curr Oncol. 2012 Aug;19(4):222-4. doi: 10.3747/co.19.1148.
Abstract
摘要
相似文献
1
Conditional survival in Canada: adjusting patient prognosis over time.加拿大的条件性生存：随时间调整患者预后。
Curr Oncol. 2012 Aug;19(4):222-4. doi: 10.3747/co.19.1148.
2
Conditional disease-free survival after surgical resection of gastrointestinal stromal tumors: a multi-institutional analysis of 502 patients.胃肠道间质瘤手术切除后的无病生存情况：502例患者的多机构分析
JAMA Surg. 2015 Apr;150(4):299-306. doi: 10.1001/jamasurg.2014.2881.
3
Impact of Relative Conditional Survival Estimates on Patient Prognosis After Percutaneous Coronary Intervention.相对条件生存估计对经皮冠状动脉介入治疗后患者预后的影响。
Circ Cardiovasc Qual Outcomes. 2017 Jun;10(6). doi: 10.1161/CIRCOUTCOMES.116.003344.
4
Outcome of Patients with Soft-Tissue Sarcomas: An Age-Specific Conditional Survival Analysis.软组织肉瘤患者的预后：年龄特异性条件生存分析。
Oncologist. 2019 Jul;24(7):e559-e564. doi: 10.1634/theoncologist.2018-0641. Epub 2019 Apr 23.
5
Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study.VEGF 靶向治疗转移性肾细胞癌患者的条件生存：一项基于人群的研究。
Lancet Oncol. 2012 Sep;13(9):927-35. doi: 10.1016/S1470-2045(12)70285-1. Epub 2012 Aug 8.
6
Conditional Survival Analysis for Spinal Chondrosarcoma Patients After Surgical Resection.脊柱软骨肉瘤患者手术后的条件生存分析。
Spine (Phila Pa 1976). 2020 Aug 15;45(16):1110-1117. doi: 10.1097/BRS.0000000000003494.
7
Conditional approval of cancer drugs in Canada: accountability and impact on public funding.加拿大癌症药物有条件批准：问责制与对公共资金的影响。
Curr Oncol. 2019 Feb;26(1):e100-e105. doi: 10.3747/co.26.4397. Epub 2019 Feb 1.
8
Conditional survival after a diagnosis of malignant brain tumour in Canada: 2000-2008.加拿大恶性脑肿瘤诊断后的条件生存情况：2000 - 2008年
Curr Oncol. 2017 Oct;24(5):e341-e347. doi: 10.3747/co.24.3579. Epub 2017 Oct 25.
9
Conditional Survival: An Assessment of the Prognosis of Patients at Time Points After Initial Diagnosis and Treatment of Locoregional Melanoma Metastasis.条件生存：局部区域黑色素瘤转移初始诊断和治疗后时间点患者预后的评估。
J Clin Oncol. 2017 May 20;35(15):1721-1729. doi: 10.1200/JCO.2016.71.9393. Epub 2017 Apr 4.
10
Conditional survival analyses across cancer sites.针对不同癌症部位的条件生存分析。
Health Rep. 2011 Jun;22(2):21-5.
引用本文的文献
1
Conditional progression-free survival in patients with metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with first-line ribociclib and endocrine therapy: real-world data from the RIBANNA study.一线使用瑞博西尼和内分泌治疗的转移性激素受体阳性、人表皮生长因子受体2阴性乳腺癌患者的条件无进展生存期：来自RIBANNA研究的真实世界数据
ESMO Open. 2025 May 16;10(6):105105. doi: 10.1016/j.esmoop.2025.105105.
2
Conditional survival to assess prognosis in patients with chronic lymphocytic leukemia.条件生存评估慢性淋巴细胞白血病患者的预后。
Ann Hematol. 2024 May;103(5):1613-1622. doi: 10.1007/s00277-024-05627-w. Epub 2024 Feb 3.
3
Conditional Survival of Patients Who Underwent Curative Resection for Esophageal Squamous Cell Carcinoma.可切除食管鳞癌患者的条件生存。
Ann Surg. 2022 Aug 1;276(2):e86-e92. doi: 10.1097/SLA.0000000000004473. Epub 2020 Oct 19.
4
One-year conditional survival of dogs and cats with invasive mammary carcinomas: A concept inspired from human breast cancer.犬猫浸润性乳腺癌的 1 年条件生存：源于人类乳腺癌的概念。
Vet Comp Oncol. 2021 Mar;19(1):140-151. doi: 10.1111/vco.12655. Epub 2020 Sep 28.
5
Provincial rates and time trends in pancreatic cancer outcomes.
Curr Oncol. 2013 Oct;20(5):279-81. doi: 10.3747/co.20.1672.
6
Conditional survival for longer-term survivors from 2000-2004 using population-based cancer registry data in Osaka, Japan.日本大阪基于人群癌症登记数据的 2000-2004 年长期生存者的条件生存。
BMC Cancer. 2013 Jun 22;13:304. doi: 10.1186/1471-2407-13-304.
本文引用的文献
1
Conditional survival analyses across cancer sites.针对不同癌症部位的条件生存分析。
Health Rep. 2011 Jun;22(2):21-5.
2
Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.澳大利亚、加拿大、丹麦、挪威、瑞典和英国的癌症生存状况，1995-2007 年（国际癌症基准合作）：基于人群的癌症登记数据分析。
Lancet. 2011 Jan 8;377(9760):127-38. doi: 10.1016/S0140-6736(10)62231-3. Epub 2010 Dec 21.
3
'Cure' from breast cancer among two populations of women followed for 23 years after diagnosis.在诊断后对两组女性人群进行了23年随访，观察她们从乳腺癌中“治愈”的情况。
Ann Oncol. 2009 Aug;20(8):1331-6. doi: 10.1093/annonc/mdn791. Epub 2009 May 22.
4
EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary.欧洲癌症患者护理与评估研究（EUROCARE）-4。1995 - 1999年确诊的癌症患者生存率。结果与评论。
Eur J Cancer. 2009 Apr;45(6):931-91. doi: 10.1016/j.ejca.2008.11.018. Epub 2009 Jan 24.
5
Cancer survival in five continents: a worldwide population-based study (CONCORD).五大洲的癌症生存率：一项基于全球人群的研究（CONCORD）
Lancet Oncol. 2008 Aug;9(8):730-56. doi: 10.1016/S1470-2045(08)70179-7. Epub 2008 Jul 17.
6
Prognosis for long-term survivors of cancer.癌症长期幸存者的预后
Ann Oncol. 2007 Aug;18(8):1408-13. doi: 10.1093/annonc/mdm127.
Zotero 插件